Diabetes and Otitis media
Summary:
Otitis media is found among people with Diabetes, especially for people who are female, 60+ old.
The study analyzes which people have Otitis media with Diabetes. It is created by eHealthMe based on reports of 63 people who have Diabetes from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Diabetes?
Diabetes is found to be associated with 2,009 drugs and 2,855 conditions by eHealthMe. Check the latest studies of Diabetes.
What is Otitis media?
Otitis media (inflammation of the middle ear) is found to be associated with 693 drugs and 663 conditions by eHealthMe. Check the latest studies of Otitis media.
63 people who have Diabetes and Otitis Media are studied.

Gender of people who have Diabetes and experienced Otitis Media *:
- female: 55.56 %
- male: 44.44 %
Age of people who have Diabetes and experienced Otitis Media *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 6.25 %
- 40-49: 8.33 %
- 50-59: 37.5 %
- 60+: 47.92 %
Common co-existing conditions for these people *:
- Depression: 23 people, 36.51%
- Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 22 people, 34.92%
- Polyp: 18 people, 28.57%
- Acinetobacter Infection (infection by group of bacteria commonly found in soil and water): 18 people, 28.57%
- Cytomegalovirus Infection: 18 people, 28.57%
- Escherichia Sepsis (bacterial infection by escherichia coli): 18 people, 28.57%
- Infection: 18 people, 28.57%
- Bacterial Infection: 18 people, 28.57%
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 17 people, 26.98%
- Pulmonary Embolism (blockage of the main artery of the lung): 16 people, 25.40%
Common drugs taken by these people *:
- Metformin: 16 people, 25.40%
- Pantoprazole: 14 people, 22.22%
- Prednisone: 9 people, 14.29%
- Insulin: 9 people, 14.29%
- Lyrica: 8 people, 12.70%
- Ceftazidime: 7 people, 11.11%
- Glimepiride: 7 people, 11.11%
- Ganciclovir: 7 people, 11.11%
- Cyclosporine: 7 people, 11.11%
- Mycophenolate Mofetil: 7 people, 11.11%
Common symptoms for these people *:
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 23 people, 36.51%
- Leukopenia (less number of white blood cells in blood): 19 people, 30.16%
- Acute Kidney Failure: 19 people, 30.16%
- Hypoproteinaemia (too little prolactin circulating in the blood): 18 people, 28.57%
- Escherichia Sepsis (bacterial infection by escherichia coli): 18 people, 28.57%
- Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 18 people, 28.57%
- Polyp: 18 people, 28.57%
- Sepsis (a severe blood infection that can lead to organ failure and death): 18 people, 28.57%
- Pulmonary Embolism (blockage of the main artery of the lung): 17 people, 26.98%
- Escherichia Urinary Tract Infection (urinary tract infection by escherichia coli): 17 people, 26.98%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Otitis media?
- Check whether Otitis media is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Diabetes (466,613 reports)
- Otitis media (6,471 reports)
All the drugs that are associated with Otitis media:
- Otitis media (693 drugs)
All the conditions that are associated with Otitis media:
- Otitis media (663 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Otitis media and Diabetes, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Onglyza vs. Repaglinide, side effect and effectiveness comparison - a second ago
- Drug interactions of Wellbutrin and Vitamin D2 - 18 seconds ago
- Drug interactions of Amiodarone Hydrochloride and Uptravi - 22 seconds ago
- Could Restoril cause Abdominal Mass? - 25 seconds ago
- Could Moviprep cause Ill-Defined Disorder? - 31 seconds ago
- Could Cozaar cause Duodenal Ulcer Haemorrhage? - 33 seconds ago
- Chest Pain and Blood Pressure Diastolic Decreased - 36 seconds ago
- Endoscopy Large Bowel Abnormal and Abdominal Pain - 52 seconds ago
- Drug interactions of Celebrex and Hctz - a minute ago
- Could Lopressor cause Necrosis? - a minute ago